Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1985 1
1986 1
1987 1
1988 1
1989 1
1990 2
1991 3
1992 3
1993 1
1995 3
1996 2
1997 10
1999 8
2000 4
2001 9
2002 14
2003 16
2004 15
2005 10
2006 8
2007 8
2008 4
2009 7
2010 4
2011 11
2012 8
2013 8
2014 3
2015 4
2016 4
2017 5
2018 9
2019 4
2020 1
2021 6
2022 6
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 2 Heartburn or Dyspepsia, CTCAE"
Page 1
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants. Yadlapati R, et al. Clin Gastroenterol Hepatol. 2022 May;20(5):984-994.e1. doi: 10.1016/j.cgh.2022.01.025. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123084 Free PMC article. Review.
BEST PRACTICE ADVICE 4: Clinicians should provide patients presenting with troublesome heartburn, regurgitation, and/or non-cardiac chest pain without alarm symptoms a 4- to 8-week trial of single-dose PPI therapy. ...BEST PRACTICE ADVICE 7: Complete endoscopic evaluation …
BEST PRACTICE ADVICE 4: Clinicians should provide patients presenting with troublesome heartburn, regurgitation, and/or non-cardiac c …
Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Weusten BLAM, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, Baldaque-Silva F, Barret M, Coron E, Fernández-Esparrach G, Fitzgerald RC, Jansen M, Jovani M, Marques-de-Sa I, Rattan A, Tan WK, Verheij EPD, Zellenrath PA, Triantafyllou K, Pouw RE. Weusten BLAM, et al. Endoscopy. 2023 Dec;55(12):1124-1146. doi: 10.1055/a-2176-2440. Epub 2023 Oct 9. Endoscopy. 2023. PMID: 37813356 Free article.
MR4: ESGE recommends offering endoscopic eradication therapy using ablation to patients with BE and low grade dysplasia (LGD) on at least two separate endoscopies, both confirmed by a second experienced pathologist.Strong recommendation, high level of evidence. MR5: ESGE r …
MR4: ESGE recommends offering endoscopic eradication therapy using ablation to patients with BE and low grade dysplasia (LGD) on at l …
Enteral nutritional therapy for induction of remission in Crohn's disease.
Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Narula N, et al. Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3. Cochrane Database Syst Rev. 2018. PMID: 29607496 Free PMC article. Review.
There was no difference between elemental and non-elemental diets in adverse event rates (RR 1.00, 95% CI 0.63 to 1.60; GRADE very low quality), or withdrawals due to adverse events (RR 1.29, 95% CI 0.80 to 2.09; GRADE very low quality). ...There was no diffe …
There was no difference between elemental and non-elemental diets in adverse event rates (RR 1.00, 95% CI 0.63 to 1.60; GRADE very lo …
Gastro-esophageal reflux disease (GERD) after peroral endoscopic myotomy (POEM).
Teh JL, Tham HY, Soh AYS, Chee C, Kim G, Shabbir A, Wong RKM, So JBY. Teh JL, et al. Surg Endosc. 2022 May;36(5):3308-3316. doi: 10.1007/s00464-021-08644-2. Epub 2021 Jul 29. Surg Endosc. 2022. PMID: 34327547
A standardized questionnaire was used to determine the severity and frequency of heartburn symptoms and the composite score for each patient was calculated. ...We observed reduction of median Integrated Relaxation Pressure (IRP) from 23.5 33.1 mmHg to 13.4 7.71 mmHg (p = 0 …
A standardized questionnaire was used to determine the severity and frequency of heartburn symptoms and the composite score for each …
Interventions for heartburn in pregnancy.
Phupong V, Hanprasertpong T. Phupong V, et al. Cochrane Database Syst Rev. 2015 Sep 19;2015(9):CD011379. doi: 10.1002/14651858.CD011379.pub2. Cochrane Database Syst Rev. 2015. PMID: 26384956 Free PMC article. Review.
Three outcomes were assessed and assigned a quality rating using the GRADE methods. Evidence from two trials for the outcome of complete relief of heartburn was assessed as of moderate quality. Evidence for the outcomes of partial heartburn relief and side ef …
Three outcomes were assessed and assigned a quality rating using the GRADE methods. Evidence from two trials for the outcome of compl …
Predictive Factors for Developing GERD After Sleeve Gastrectomy: Is Preoperative Endoscopy Necessary?
Bellorin O, Senturk JC, Cruz MV, Dakin G, Afaneh C. Bellorin O, et al. J Gastrointest Surg. 2022 May;26(5):1015-1020. doi: 10.1007/s11605-021-05207-7. Epub 2022 Jan 8. J Gastrointest Surg. 2022. PMID: 34997468
Patients with a positive preoperative pH test, LA Grade B or greater esophagitis, or hiatal hernia > 5 cm on preoperative endoscopy were counseled to undergo gastric bypass and excluded. ...On multivariate analysis, the strongest predictors of GERD after SG were endosco …
Patients with a positive preoperative pH test, LA Grade B or greater esophagitis, or hiatal hernia > 5 cm on preoperative endoscop …
Management advice for patients with reflux-like symptoms: an evidence-based consensus.
Hungin AP, Yadlapati R, Anastasiou F, Bredenoord AJ, El Serag H, Fracasso P, Mendive JM, Savarino EV, Sifrim D, Udrescu M, Kahrilas PJ. Hungin AP, et al. Eur J Gastroenterol Hepatol. 2024 Jan 1;36(1):13-25. doi: 10.1097/MEG.0000000000002682. Eur J Gastroenterol Hepatol. 2024. PMID: 38006602 Free PMC article.
Patients with reflux-like symptoms (heartburn and regurgitation) are often not well advised on implementing individualised strategies to help control their symptoms using dietary changes, lifestyle modifications, behavioural changes or fast-acting rescue therapies. ...Afte …
Patients with reflux-like symptoms (heartburn and regurgitation) are often not well advised on implementing individualised strategies …
Pepsin and pH of Gastric Juice in Patients With Gastrointestinal Reflux Disease and Subgroups.
Ergun P, Kipcak S, Dettmar PW, Fisher J, Woodcock AD, Bor S. Ergun P, et al. J Clin Gastroenterol. 2022 Jul 1;56(6):512-517. doi: 10.1097/MCG.0000000000001560. Epub 2021 May 28. J Clin Gastroenterol. 2022. PMID: 34049376
STUDY: Ninety patients with GERD, 39 erosive reflux disease (ERD) Los Angeles (LA) grade A/B, 13 ERD LA grade C/D, 19 nonerosive reflux disease (NERD), 8 esophageal hypersensitivity, 11 functional heartburn, and 24 healthy controls were included in the study. …
STUDY: Ninety patients with GERD, 39 erosive reflux disease (ERD) Los Angeles (LA) grade A/B, 13 ERD LA grade C/D, 19 nonerosi …
The Effect of Dexlansoprazole on Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
Nunes GP, Silveira TC, Marciano JVS, Dos Reis-Prado AH, Ferrisse TM, Dos Anjos EB, Fernandes MH. Nunes GP, et al. Int J Mol Sci. 2024 Jan 19;25(2):1247. doi: 10.3390/ijms25021247. Int J Mol Sci. 2024. PMID: 38279248 Free PMC article. Review.
Only randomized clinical trials (RCTs) were included. The Cochrane tool (RoB 2.0) was used to assess the risk of bias, and the certainty of evidence was rated using GRADE. ...The meta-analyses indicated that dexlansoprazole at doses of 30 and 60 mg had more 24 h …
Only randomized clinical trials (RCTs) were included. The Cochrane tool (RoB 2.0) was used to assess the risk of bias, and the certai …
Lansoprazole for maintenance of remission of erosive oesophagitis.
Freston JW, Jackson RL, Huang B, Ballard ED 2nd. Freston JW, et al. Drugs. 2002;62(8):1173-84. doi: 10.2165/00003495-200262080-00004. Drugs. 2002. PMID: 12010078 Review.
These high rates of remission have also been observed in studies of patients with lesions that were difficult to heal at baseline (resistant to healing with at least 3 months of H(2) antagonist therapy). Moreover, lansoprazole produces high remission rates regardless of th …
These high rates of remission have also been observed in studies of patients with lesions that were difficult to heal at baseline (resistant …
197 results